Hill-Rom Holdings ROE 2006-2018 | HRC

Current and historical return on equity (ROE) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Hill-Rom Holdings ROE for the three months ending December 31, 2018 was 21.23%.
Hill-Rom Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.21B $1.55B 13.32%
2018-09-30 $0.25B $1.62B 16.53%
2018-06-30 $0.23B $1.51B 15.80%
2018-03-31 $0.19B $1.51B 13.64%
2017-12-31 $0.20B $1.46B 14.66%
2017-09-30 $0.13B $1.37B 10.42%
2017-06-30 $0.12B $1.29B 9.33%
2017-03-31 $0.16B $1.25B 12.70%
2016-12-31 $0.14B $1.20B 11.90%
2016-09-30 $0.12B $1.24B 10.42%
2016-06-30 $0.06B $1.20B 5.30%
2016-03-31 $0.04B $1.18B 3.39%
2015-12-31 $0.04B $1.15B 4.22%
2015-09-30 $0.05B $1.16B 5.55%
2015-06-30 $0.08B $0.77B 10.79%
2015-03-31 $0.09B $0.72B 11.48%
2014-12-31 $0.06B $0.74B 7.54%
2014-09-30 $0.06B $0.81B 7.44%
2014-06-30 $0.07B $0.83B 8.52%
2014-03-31 $0.07B $0.80B 8.23%
2013-12-31 $0.09B $0.84B 11.23%
2013-09-30 $0.10B $0.86B 12.63%
2013-06-30 $0.11B $0.81B 13.30%
2013-03-31 $0.11B $0.81B 13.27%
2012-12-31 $0.11B $0.82B 13.69%
2012-09-30 $0.12B $0.81B 15.04%
2012-06-30 $0.15B $0.81B 18.58%
2012-03-31 $0.12B $0.80B 16.19%
2011-12-31 $0.13B $0.77B 17.45%
2011-09-30 $0.13B $0.74B 17.96%
2011-06-30 $0.12B $0.75B 16.40%
2011-03-31 $0.15B $0.76B 20.87%
2010-12-31 $0.14B $0.73B 20.41%
2010-09-30 $0.13B $0.71B 18.95%
2010-06-30 $0.10B $0.68B 15.78%
2010-03-31 $0.09B $0.65B 14.48%
2009-12-31 $-0.40B $0.63B -66.20%
2009-09-30 $-0.41B $0.61B -56.92%
2009-06-30 $-0.41B $0.60B -49.05%
2009-03-31 $-0.41B $0.58B -42.91%
2008-12-31 $0.08B $1.06B 7.86%
2008-09-30 $0.12B $1.08B 10.17%
2008-06-30 $0.14B $1.08B 11.79%
2008-03-31 $0.16B $1.05B 12.67%
2007-12-31 $0.18B $1.31B 14.55%
2007-09-30 $0.19B $1.28B 15.53%
2007-06-30 $0.21B $1.26B 17.59%
2007-03-31 $0.23B $1.22B 19.60%
2006-12-31 $0.23B $1.17B 20.40%
2006-09-30 $0.22B $1.13B 20.84%
2006-06-30 $-0.08B $1.07B -7.45%
2006-03-31 $-0.09B $1.04B -8.63%
2005-12-31 $-0.09B $1.00B -8.52%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.962B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.32
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
HEXO (HEXO) $1.340B 0.00
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
InfuSystems Holdings (INFU) United States $0.091B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29